COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 424: Articles 4231-4240  | Next

A new tractable method for generating Human Alveolar Macrophage Like cells in vitro to study lung inflammatory processes and diseases
Pahari, S., Arnett, E., Simper, J., Azad, A., Guerrero-Arguero, I., Ye, C., Zhang, H., Cai, H., Wang, Y., Lai, Z., Jarvis, N., Lumbreras, M., Maselli-Caceres, D. J., Peters, J. I., Torrelles, J. B., Mart ínez-Sobrido, L., Schlesinger, L. S.
10.1101/2023.04.05.535806 — Posted: 2023-04-08
Integration of serial self-testing for COVID-19 as part of contact tracing in the Brazilian public health system: A pragmatic trial protocol
Green, R., Manchola, C., Gerth-Guyette, E., Oliveira Silva, M., Stephanie, R., dos Santos Soares, T., Bastos Gottin, L., Coelho, M., Green, K. E., Dias Tavares Costa, A., Batista Pereira, D.
10.1101/2023.04.05.23288207 — Posted: 2023-04-07
Silymarin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells
Nnadi, N. E., Luka, P. D., Omale, S., Shehu, N. Y., Aguiyi, J. C.
10.1101/2023.04.07.535766 — Posted: 2023-04-07
The role of N-glycosylation in spike antigenicity for the SARS-CoV-2 Gamma variant
Pegg, C. L., Modhiran, N., Parry, R., Liang, B., Amarilla, A. A., Khromykh, A., Burr, L., Young, P., Chappell, K., Schulz, B. L., Watterson, D.
10.1101/2023.04.03.535004 — Posted: 2023-04-07
Longitudinal study of humoral immunity against SARS-CoV-2 of health professionals in Brazil: the impact of booster dose and reinfection on antibody dynamics
Franco-Luiz, A. P., Fernandes, N. M. G. S., Silva, T. B. d. S., Bernardes, W. P. d. O. S., Westin, M. R., Santos, T. G., Fernandes, G. R., Simoes, T. C., Fernandes e Silva, E., Gava, S. G., Alves, B. M., Melo, M. d. C., Silva-Pereira, R. A. d., Alves, P. A., Toscano Fonseca, C.
10.1101/2023.04.03.535504 — Posted: 2023-04-07
Direct and indirect impact of the COVID-19 pandemic on the survival of kidney transplant recipients: a national observational study in France.
Leye, E., Delory, T., El Karoui, K., Espagnacq, M., Khlat, M., Le Coeur, S., Lapidus, N., Hejblum, G., COVID-HOSP working group
10.1101/2023.04.05.23288113 — Posted: 2023-04-06
Incidence of Symptoms Associated with Post-Acute Sequelae of SARS-CoV-2 infectionin Non-Hospitalized Vaccinated Patients Receiving Nirmatrelvir-Ritonavir
PATEL, R., Dani, S. S., Khadke, S., Ahmad, J., Shah, J., Mehta, N., Wener, K., McQuillen, D. P., Abraham, G., Faust, J., Maley, J., Patel, S., Mullington, J., Wachter, R., Mosenthal, A., Sax, P., Ganatra, S.
10.1101/2023.04.05.23288196 — Posted: 2023-04-06
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines in Immunocompromised Individuals: A Systematic Review and Meta-Analysis Using the GRADE Framework
Wang, X., Haeussler, K., Spellman, A., Phillips, L., Ramiller, A., Bausch-Jurken, M., Sharma, P., Krivelyova, A., Vats, S., Van de Velde, N.
10.1101/2023.04.05.23288195 — Posted: 2023-04-06
Pre-infection neutralizing antibodies, Omicron BA.5 breakthrough infection, and long COVID: a propensity score-matched analysis
Yamamoto, S., Matsuda, K., Maeda, K., Horii, K., Okudera, K., Oshiro, Y., Inamura, N., Nemoto, T., TAKEUCHI, J. S., Li, Y., Konishi, M., Tsuchiya, K., Gatanaga, H., Oka, S., Mizoue, T., Sugiyama, H., Aoyanagi, N., Mitsuya, H., Sugiura, W., Ohmagari, N.
10.1101/2023.04.05.23288162 — Posted: 2023-04-06
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.16 variant
Yamasoba, D., Uriu, K., Plianchaisuk, A., Kosugi, Y., Pan, L., Zahradnik, J., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Ito, J., Sato, K.
10.1101/2023.04.06.535883 — Posted: 2023-04-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).